☰

Jelena Tomic, Ph.D. - Publications

Affiliations: 
2012 Medical Biophysics University of Toronto, Toronto, ON, Canada 
Area:
Medical Biophysics, Cell Biology, Biochemistry, Oncology, Immunology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mair B, Tomic J, Masud SN, Tonge P, Weiss A, Usaj M, Tong AHY, Kwan JJ, Brown KR, Titus E, Atkins M, Chan KSK, Munsie L, Habsid A, Han H, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Reports. 27: 599-615.e12. PMID 30970261 DOI: 10.1016/J.Celrep.2019.02.041  0.303
2016 Tomic J, McLaughlin M, Geyer R, Sidhu S, Moffat J. Abstract 2972: Development and characterization of synthetic antibodies with a human framework that directly link metabolism to immune system in cancer cells Cancer Research. 76: 2972-2972. DOI: 10.1158/1538-7445.Am2016-2972  0.379
2013 Tomic J, McCaw L, Li Y, Hough MR, Ben-David Y, Moffat J, Spaner DE. Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins. Experimental Hematology. 41: 675-86. PMID 23597602 DOI: 10.1016/J.Exphem.2013.04.004  0.542
2011 Tomic J, Lichty B, Spaner DE. Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia. Blood. 117: 2668-80. PMID 21205928 DOI: 10.1182/Blood-2010-05-285999  0.596
2010 Shi Y, Tomic J, Wen F, Shaha S, Bahlo A, Harrison R, Dennis JW, Williams R, Gross BJ, Walker S, Zuccolo J, Deans JP, Hart GW, Spaner DE. Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia. 24: 1588-98. PMID 20668475 DOI: 10.1038/Leu.2010.152  0.572
2009 Shaha SP, Tomic J, Shi Y, Pham T, Mero P, White D, He L, Baryza JL, Wender PA, Booth JW, Spaner DE. Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells. Clinical and Experimental Immunology. 158: 186-98. PMID 19737143 DOI: 10.1111/J.1365-2249.2009.04003.X  0.622
2009 Hammond CM, Shi Y, White D, Cervi D, Tomic J, Spaner DE. The B-cell calcium sensor predicts progression of chronic lymphocytic leukemia. Leukemia. 23: 426-9. PMID 19078991 DOI: 10.1038/Leu.2008.351  0.532
2007 Hammond CM, White D, Tomic J, Shi Y, Spaner DE. Extracellular calcium sensing promotes human B-cell activation and function. Blood. 110: 3985-95. PMID 17724142 DOI: 10.1182/Blood-2007-05-088468  0.585
2006 Tomic J, White D, Shi Y, Mena J, Hammond C, He L, Miller RL, Spaner DE. Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 176: 3830-9. PMID 16517754 DOI: 10.4049/Jimmunol.176.6.3830  0.595
2006 Spaner DE, Shi Y, White D, Mena J, Hammond C, Tomic J, He L, Tomai MA, Miller RL, Booth J, Radvanyi L. Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia. 20: 286-95. PMID 16341037 DOI: 10.1038/Sj.Leu.2404061  0.633
2005 Hammond C, Shi Y, Mena J, Tomic J, Cervi D, He L, Millar AE, Debenedette M, Schuh AC, Baryza JL, Wender PA, Radvanyi L, Spaner DE. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells. Journal of Immunotherapy (Hagerstown, Md. : 1997). 28: 28-39. PMID 15614042 DOI: 10.1097/00002371-200501000-00004  0.635
Show low-probability matches.